Search results
Most young women treated for breast cancer can hav | Newswise
Newswise· 5 days agoNew research by Dana-Farber Cancer Institute investigators has encouraging news for young women who...
Is Vaginal Estrogen Safe in Breast Cancer Survivors?
Medscape· 5 days agoVaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with HR-positive tumors concurrently...
29 Celebrities Who Have Had Breast Cancer
SheKnows via Yahoo News· 6 days agoFrom A-list celebrities to the people in our own lives, breast cancer can can truly happen to anyone — and the stats show it. After skin cancer ...
Olivia Munn Details Emotional Moment She Was Diagnosed With Cancer
Entertainment Tonight· 7 days agoOlivia Munn continues to get candid about her harrowing experience with breast cancer. On Tuesday's...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 6 days agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced ...
PKMYT1, a potential 'Achilles heel' of treatment resistant ER+ breast cancers with the poorest...
Medical Xpress· 3 days agoLooking to identify new vulnerabilities in this type of cancer that could lead to improved...
Can diet help with advanced breast cancer? All indications are positive, researchers say
Medical Xpress· 5 days agoThe outcomes are from a small study by researchers at the University of Rochester Medical Center and...
Olivia Munn’s Breast Cancer Journey in Her Own Words: What She’s Said About Her Health Battle
Us Weekly via Yahoo News· 6 days agoOlivia Munn initially chose to keep her breast cancer diagnosis private, but she’s shared plenty of...
ADCs for Breast Cancer: Clear Benefits, Manageable Risks
Medscape· 7 days agoADCs are rapidly changing the treatment landscape for patients with metastatic breast cancer, with the agents demonstrating improved efficacy and manageable risks.
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
FOX 4 Kansas City· 4 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical...